(Chr) 8. Human (RH): SLUGH/DSS2090 Chr 8 at 66-69 cM.
Methods of mapping:
Mouse linkage analysis with 94 N 2 progeny from The Jackson Laboratory interspecific backcross panel [C57BL/6JEi x SPRET/Ei]F 1 x SPRET/Ei (Jackson BSS, Jackson Laboratory) [1] (Fig. 1 ). Human chromosome assignment by somatic cell hybrid analysis (BIOS) (Fig. 2 ). Human mapping with 83 human-rodent G3 radiation hybrid cell lines (Research Genetics).
Molecular reagents used for mapping:
For Southern and Northern blot hybridization, a Slugh probe, including bp 45 to 432 from mouse Slugh cDNA sequence was excised from PCR II constructs previously described [2] . Far radiation hybrid mapping, a human ortholog of Slugh was identified from the expressed sequence tag (dbEST) database'using (BLASTN). Several ESTs were identified (Clone identification numbers 261671, 270049, 268993, 269377, 272919, 292023 ) that were overlapping clones (98% nucleic acid identity over 300 bases) and shared 62-82% nucleic acid sequence identity over different portions of the mouse Slugh cDNA. Consistent with this finding, these ESTs also exhibit 100% nucleic acid identity to a partial human ortholog of Slug [2] . Allele detection: Mouse linkage analysis: ApaI digestion resulted in different-sized restriction fragments (14.5 kb in C57BL/6J and 13 kb in Mus spretus/ei). Somatic cell hybrid analysis: EcoRI digestion resulted in different-sized restriction enzyme fragments (10 kb in human, 6 kb in mouse, and 11 kb in hamster). For radiation hybrid mapping, the 3' sequence of human SLUGH EST clone 292023 was used to design human-specific PCR oligonucleotides: 5'SLUG atgggaataagtgcaaaagag and 3'SLUG agacaacatctcagtttcata. The presence or absence of a human SLUGH-specific, 210-bp PCR product was determined for the 83 human-rodent RH cell lines. Raw scoring data: 0000000000 0100111010 00000100000000000001 0001001000 0101011101 1011001000
Correspondence to: W.J. Pavan Discussion: The molecular events involved in conversion of pleuripotent epithelial derivatives into various neural crest derivatives require complex cellular and environmental interactions modulated by lineage-specific transcription factors. One important event in the development of neural crest-derived cells is the transition of epithelial to mesenchymal characteristics during emigration from the neural tube. Slug, a zinc finger protein, is one gene believed to play an important role in this transition [2, 3] . Slug is a neurogenic, transcription factor belonging to the Snail family in Drosophila melanogaster. Embryological studies in chick and frog demonstrated that Slug mRNA is expressed in the developing neural crest and in mesodermal cells emerging from the primitive streak [3] [4] [5] . Indirect functional analyses with antisense oligonucleotides to the Slug mRNA showed specific and transient developmental failures at the early embryonic stages. These failures resulted in defects in neural tube closure between the midbrain and cervical regions, block of the epithelial-mesenchymal transition in the neural crest, and in the emergence of mesoderm from the primitive streak. These anomalies suggest that SLUG is required for the genetic control of cell activity during early stages of neural tube and neural crest development. Consistent with a role for SLUGH function in mouse embryonic development, our Northern blot analyses demonstrated that Slugh is expressed at 7 days p.c., and the signal intensity decreases subsequent to 11 days p.c. Further experiments with in situ hybridization or immunohistochemistry will be necessary to determine the specific sites of Slug expression during mouse embryogenesis.
Identification of known mutations caused by alterations of specific genes can provide essential clues for understanding the normal function of those genes in mammalian development. To determine whether Slugh is a candidate gene for a disease locus, we identified the chromosomal localization of Slugh in the mouse and human genomes. Segregation analysis of a Slugh RFLP in The Jackson Laboratory FI(C57BL/6J x Mus spretus) x Mus spretus (BSS) interspecific backcross panel [1] determined that the mouse Slugh gene is located on the proximal end of Chr 16 and cosegregated with four previously mapped loci: Tbxl (T/omb homologous domain containing gene 1), D16Bir4, D16Hun3, and Gplbb (Fig. 1 ).
An interspecies somatic-cell hybrid (SCH) panel was used to determine the chromosomal localization of SLUGH in the human genome. The mouse Slugh cDNA hybridized to a human-specific 10 kb band in two SCH lanes: one SCH cell line containing only human Chr 8; the other SCH cell line containing three human chromosomes, 4, 8, and 20 (Fig. 2) . This result indicated that SLUGH was located on human Chr 8. Only one other gene, a CCAAT/enhancer binding protein, C/EBP-delta (CRP3/CELF), has been localized to this portion of human Chr 8 and mouse Chr 16 ( [6] , mouse human homology map http://www3.ncbi.nlm.nih. gov/Homology/mousel6.html). Therefore, to confirm and further refine the localization of Slugh in the human genome, we identified a human SLUGH EST and determined its human map location with the Stanford G3 radiation hybrid (RH) mapping panel (http:// shgc.stanford.edu/RH/index.html). Comparison of RH mapping data with previously scored markers determined that SLUGH was closely linked to marker D8S2090 (LOD 15) 
